Walgreens Tops Estimates as Prescriptions Make Up for RetailBy
U.S. same-store retail segment sales decline 0.6 percent
Earnings are $1.03 a share, top analysts' estimate by 7 cents
Walgreens Boots Alliance Inc. beat analysts’ earnings estimates of fiscal first-quarter earnings estimates, as strong prescription drug trends made up for a retail slump that continues to affect the company.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.